Published in Vaccine Weekly, September 13th, 2006
"The immunogenicity and reactogenicity, in British school children, of the newly introduced Danish-SSI 1331 BCG vaccine was compared with that of the previously used Glaxo-Evans 1077 BCG vaccine," researchers in the U.K. report.
"Interferon-gamma (IFN-gamma) response to M. tuberculosis purified protein derivative (M.tb PPD) in a six-day whole blood assay and delayed type hypersensitivity (DTH) to tuberculin PPD were determined before and one year after receiving BCG or no vaccination. Scar size was measured one year after vaccination," explained...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly